Clinical trial NCT07434973
Status: Not yet recruitingPhase 3Latest change: Source: ClinicalTrials.gov
What's on this page?
Information in the record
Original title: Stratification and Treatment in Early Psychosis Study - PROMOTE
- Record number
- NCT07434973
- Status
- Not yet recruiting
- Type and phase
- Clinical trial, phase 3
- Participants
- Target: 586
- Condition (as registered)
- Clinical High Risk for Psychosis (CHR), Clinical High Risk for Psychosis, Clinical High Risk for Developing Psychosis
- Countries
- Austria, Canada, Finland, Germany, Greece, Italy, Netherlands, Spain, Switzerland, United Kingdom
- Topic in the guide
- Schizophrenia
Timeline
According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.
- Start: December 1, 2026 (expected)
- End of data collection for primary results: December 1, 2029 (expected)
- Trial completion: December 1, 2031 (expected)
History
We check the record every day; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Not yet recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Schizophrenia: ongoing trials · Thinking of taking part? Which specialist to see